Category: News
PRESS RELEASE: aTyr Pharma announces pulmonary sarcoidosis trial in collaboration with FSR
aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR) FSR Clinical Studies Network to assist with clinical site initiation to expedite...
Zach Kerr spotlights FSR for My Cause, My Cleats
Denver Broncos defensive end Zach Kerr will be wearing purple kicks for the next few weeks to show his support in raising awareness about sarcoidosis. Zach selected FSR as his charity of choice for the NFL’s My Cause, My Cleats campaign this year. Zach’s...
Orphan Drug Act: Celebrating 35 Years
The Orphan Drug Act has been helping sarcoidosis patients receive better treatment options for the last 35 years. Help us ensure its future!
Interview to Understand Experience Living with Sarcoidosis
A doctoral student at Northcentral University is doing a research study about the experience of living with sarcoidosis. Participants must: Be age 21 years or older Have had sarcoidosis for at least one year Or Live with a family member for at least one year that has...
Application Cycle for 2019-20 Patient Ambassador Program Term Now Open!
We are thrilled to announce that applications are now being accepted for the 2019-2020 term of the FSR Patient Ambassador Program.
Clinical Studies Network (2019 Update)
In 2019 the Clinical Studies Network (CSN) will conduct a study focused on cardiac sarcoidosis at all 12 of our sites.
Registration Open for Early 2019 Patient Conferences!
Registration is now open for the first FSR Patient Conferences of 2019! Whether you are newly diagnosed or have had sarcoidosis for many years, FSR Patient Conferences are a great way to learn about the disease and become connected with others that are dealing with...
FSR Attends Hill Day
On Oct. 2nd and 3rd FSR’s Executive Director, Ginger Spitzer, was able to travel with PAR to Washington D.C for ATS Hill Day.
